Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRL1 | P41146 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
| ▸ | DGAT2 | Q96PD7 | 5/20 | 0.36 |
| ▸ | MALT1 | Q9UDY8 | 5/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.35 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL45195 | 0.88 | OPRL1 (0.39) | OPRL1DGAT2TRPA1TRPV1KDM4E | |
| SCHEMBL45196 | 0.83 | OPRL1 (0.37) | OPRL1DGAT2TRPA1TRPV1 | |
| SCHEMBL45013 | 0.81 | OPRL1 (0.41) | OPRL1DGAT2MALT1KMT2A | |
| SCHEMBL384694 | 0.80 | ALDH1A1 (0.45) | MALT1MEN1ALDH1A1KMT2A | |
| SCHEMBL45318 | 0.78 | KMT2A (0.41) | MALT1MEN1ALDH1A1KMT2A | |
| SCHEMBL46957 | 0.78 | OPRL1 (0.35) | OPRL1DGAT2MALT1TRPV1 | |
| SCHEMBL44847 | 0.77 | TRPV1 (0.53) | TRPA1TRPV1MEN1KMT2A | |
| SCHEMBL10118297 | 0.77 | OPRL1 (0.36) | OPRL1DGAT2 | |
| SCHEMBL10118298 | 0.76 | OPRL1 (0.35) | OPRL1DGAT2 | |
| SCHEMBL384207 | 0.74 | KDM4E (0.41) | OPRL1MALT1TRPA1TRPV1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2582688-B1 | ANTHRANILIC ACID DIAMIDE DERIVATIVES | BAYER IP GMBH (DE) | 2015-10-07 | — | — | EP | disclosed |
| US-8791139-B2 | Anthranilic diamide derivatives | BAYER CROPSCIENCE AG (DE) | 2014-07-29 | — | — | US | disclosed |
| EP-2582688-A1 | ANTHRANILIC ACID DIAMIDE DERIVATIVES | Bayer Intellectual Property GmbH (DE) | 2013-04-24 | — | — | EP | disclosed |
| CN-103068813-A | Anthranilic acid diamide derivatives | BAYER CROPSCIENCE AG | 2013-04-24 | — | — | CN | disclosed |
| US-20120015980-A1 | ANTHRANILIC DIAMIDE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2012-01-19 | — | — | US | disclosed |
| WO-2011157654-A1 | ANTHRANILIC ACID DIAMIDE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2011-12-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120015980-A1 | ANTHRANILIC DIAMIDE DERIVATIVES | DDT, QDPR, ANTXR2 | OPRL1 3656/4885PTPN1 1154/4885DGAT2 2203/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.